anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Nuvectis Pharma | Investor Presentation Deck | 25 slides · page 11 of 25

The slide presents three separate line charts showing tumor growth inhibition over time for different cell lines (RL95-2, KLE, SNG-M).

Pitch deck · traction · show_traction · dense density

Deck inventory Unlock
More
Slide JSON Deck JSON
Slide locked Sign in to view
Slide schematic 5/5
chart 3/3 list 1/1 title 1/1
Components 5
line line line bullet headline
Tools 1
Small Multiples slide · 80%

chart/line: KLE (ARID1b mutation/poorly differentiated) tumor volume over time, chart/line: RL95-2 (ARID1a/ARID1b concurrent mutation) tumor volume over time, chart/line: SNG-M (ARID1a mutation) tumor volume over time
Metrics 0
∅
No metrics

No metric insight is anchored to this slide.

Frameworks 0
∅
No frameworks

No framework match is anchored to this slide.